Man Group PLC : Form 8.3 - FORM 8.3 PUBLIC

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
524
Man Group PLC : Form 8.3 - [GVC Holdings plc]

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Man Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):                                                                      N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:                                                                      GVC Holdings plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:                                                                      14 th December 2017
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      YES / NO / N/A If YES, specify which: Ladbrokes Coral Group plc

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:   Euro 0.01 ordinary
    Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 674,384     0.2222   0 0
(2) Cash-settled derivatives:   6,586,746   2.1698   1,060,713       0.3494  
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0 0 0
       TOTAL: 7,261,130     2.3920   1,060,713       0.3494  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchase/sale   Number of securities Price per unit
Euro 0.01 ordinary Purchase 349 9.1400
Euro 0.01 ordinary Purchase 12,020 9.1819
Euro 0.01 ordinary Purchase 19,504 9.2650

(b)        Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP)
Euro 0.01 ordinary CFD Increasing a long position 1094 9.21840
Euro 0.01 ordinary CFD Reducing a short position 24 9.22750
Euro 0.01 ordinary CFD Increasing a long position 28488 9.21840
Euro 0.01 ordinary CFD Increasing a long position 85 9.21830
Euro 0.01 ordinary CFD Increasing a long position 70 9.21830
Euro 0.01 ordinary CFD Increasing a long position 1637 9.21830
Euro 0.01 ordinary CFD Increasing a long position 1496 9.21830
Euro 0.01 ordinary CFD Increasing a long position 56 9.21840
Euro 0.01 ordinary CFD Increasing a long position 1168 9.21840
Euro 0.01 ordinary CFD Increasing a long position 574 9.21830
Euro 0.01 ordinary CFD Increasing a long position 147 9.21830
Euro 0.01 ordinary CFD Increasing a long position 243 9.21840
Euro 0.01 ordinary CFD Opening a long position 17490 9.26500
Euro 0.01 ordinary CFD Increasing a long position 3736 9.18190
Euro 0.01 ordinary CFD Opening a long position 10777 9.18190
Euro 0.01 ordinary CFD Increasing a long position 6063 9.26500
Euro 0.01 ordinary CFD Increasing a long position 108 9.14000
Euro 0.01 ordinary CFD Opening a long position 313 9.14000
Euro 0.01 ordinary CFD Increasing a long position 20789 9.08500
Euro 0.01 ordinary CFD Increasing a long position 454 9.08610
Euro 0.01 ordinary CFD Increasing a long position 240 9.10970
Euro 0.01 ordinary CFD Increasing a long position 95 9.14000
Euro 0.01 ordinary CFD Increasing a long position 26390 9.21720
Euro 0.01 ordinary CFD Opening a long position 33750 9.07460
Euro 0.01 ordinary CFD Increasing a long position 212 9.10970
Euro 0.01 ordinary CFD Increasing a long position 18204 9.08500
Euro 0.01 ordinary CFD Increasing a long position 399 9.08610
Euro 0.01 ordinary CFD Increasing a long position 9178 9.09590
Euro 0.01 ordinary CFD Increasing a long position 5135 9.17650
Euro 0.01 ordinary CFD Increasing a long position 3272 9.18190
Euro 0.01 ordinary CFD Increasing a long position 5308 9.26500
Euro 0.01 ordinary CFD Increasing a long position 761 9.20390
Euro 0.01 ordinary CFD Increasing a long position 1073 9.20390
Euro 0.01 ordinary CFD Increasing a long position 4679 9.18190
Euro 0.01 ordinary CFD Increasing a long position 138 9.14000
Euro 0.01 ordinary CFD Increasing a long position 13083 9.09590
Euro 0.01 ordinary CFD Opening a long position 48219 9.07460
Euro 0.01 ordinary CFD Increasing a long position 7320 9.17650
Euro 0.01 ordinary CFD Increasing a long position 571 9.08610
Euro 0.01 ordinary CFD Increasing a long position 26036 9.08500
Euro 0.01 ordinary CFD Increasing a long position 37622 9.21720
Euro 0.01 ordinary CFD Increasing a long position 7590 9.26500
Euro 0.01 ordinary CFD Increasing a long position 302 9.10970
Euro 0.01 ordinary CFD Increasing a long position 68 9.08610
Euro 0.01 ordinary CFD Increasing a long position 16 9.14000
Euro 0.01 ordinary CFD Increasing a long position 4545 9.21720
Euro 0.01 ordinary CFD Opening a long position 5831 9.07460
Euro 0.01 ordinary CFD Increasing a long position 3141 9.08500
Euro 0.01 ordinary CFD Increasing a long position 36 9.10970
Euro 0.01 ordinary CFD Increasing a long position 1580 9.09590
Euro 0.01 ordinary CFD Increasing a long position 884 9.17650
Euro 0.01 ordinary CFD Increasing a long position 917 9.26500
Euro 0.01 ordinary CFD Increasing a long position 564 9.18190
Euro 0.01 ordinary CFD Increasing a long position 109 9.20390
Euro 0.01 ordinary CFD Increasing a long position 193 9.20390
Euro 0.01 ordinary CFD Increasing a long position 1358 9.26500
Euro 0.01 ordinary CFD Increasing a long position 24 9.14000
Euro 0.01 ordinary CFD Increasing a long position 837 9.18190
Euro 0.01 ordinary CFD Increasing a long position 1308 9.17650
Euro 0.01 ordinary CFD Increasing a long position 4656 9.08500
Euro 0.01 ordinary CFD Increasing a long position 2338 9.09590
Euro 0.01 ordinary CFD Increasing a long position 101 9.08610
Euro 0.01 ordinary CFD Opening a long position 8602 9.07460
Euro 0.01 ordinary CFD Increasing a long position 6726 9.21720
Euro 0.01 ordinary CFD Increasing a long position 53 9.10970
Euro 0.01 ordinary CFD Opening a long position 12376 9.26500
Euro 0.01 ordinary CFD Opening a long position 9731 9.18190
Euro 0.01 ordinary CFD Opening a long position 258 9.10970
Euro 0.01 ordinary CFD Opening a long position 2635 9.08500
Euro 0.01 ordinary CFD Increasing a long position 1889 9.21720
Euro 0.01 ordinary CFD Opening a long position 2444 9.07460
Euro 0.01 ordinary CFD Increasing a long position 45 9.10970
Euro 0.01 ordinary CFD Increasing a long position 15 9.10970
Euro 0.01 ordinary CFD Increasing a long position 86 9.08610
Euro 0.01 ordinary CFD Increasing a long position 28 9.08610
Euro 0.01 ordinary CFD Increasing a long position 656 9.09590
Euro 0.01 ordinary CFD Increasing a long position 3953 9.08500
Euro 0.01 ordinary CFD Increasing a long position 1316 9.08500
Euro 0.01 ordinary CFD Increasing a long position 367 9.17650
Euro 0.01 ordinary CFD Increasing a long position 236 9.18190
Euro 0.01 ordinary CFD Increasing a long position 710 9.18190
Euro 0.01 ordinary CFD Opening a long position 1898 9.18190
Euro 0.01 ordinary CFD Increasing a long position 384 9.26500
Euro 0.01 ordinary CFD Increasing a long position 1154 9.26500
Euro 0.01 ordinary CFD Opening a long position 3080 9.26500
Euro 0.01 ordinary CFD Increasing a long position 6 9.14000
Euro 0.01 ordinary CFD Increasing a long position 20 9.14000
Euro 0.01 ordinary CFD Opening a long position 55 9.14000
Euro 0.01 ordinary CFD Reducing a long position 123 9.21750
Euro 0.01 ordinary CFD Reducing a long position 2865 9.21750
Euro 0.01 ordinary CFD Reducing a long position 2266 9.16020
Euro 0.01 ordinary CFD Reducing a long position 1843 9.16600
Euro 0.01 ordinary CFD Increasing a long position 3 9.14000
Euro 0.01 ordinary CFD Increasing a long position 194 9.26500
Euro 0.01 ordinary CFD Increasing a long position 119 9.18190
Euro 0.01 ordinary CFD Increasing a long position 147 9.17650
Euro 0.01 ordinary CFD Increasing a long position 664 9.08500
Euro 0.01 ordinary CFD Increasing a long position 264 9.09590
Euro 0.01 ordinary CFD Increasing a long position 14 9.08610
Euro 0.01 ordinary CFD Increasing a long position 7 9.10970
Euro 0.01 ordinary CFD Increasing a long position 760 9.21720
Euro 0.01 ordinary CFD Opening a long position 1154 9.07460
Euro 0.01 ordinary CFD Reducing a long position 887 9.17920
Euro 0.01 ordinary CFD Reducing a long position 1486 9.17920
Euro 0.01 ordinary CFD Reducing a long position 323 9.21750
Euro 0.01 ordinary CFD Reducing a short position 4010 9.20130
Euro 0.01 ordinary CFD Reducing a short position 1960 9.20130
Euro 0.01 ordinary CFD Reducing a short position 1180 9.20130
Euro 0.01 ordinary CFD Reducing a short position 4220 9.20130
Euro 0.01 ordinary CFD Opening a long position 72385 9.26500
Euro 0.01 ordinary CFD Opening a long position 44607 9.18190
Euro 0.01 ordinary CFD Opening a long position 1295 9.14000
Euro 0.01 ordinary CFD Increasing a short position 11800 9.19790

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit
           

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
       

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
  None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None  

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES/ NO
Date of disclosure: 15 th December 2017
Contact name: Matthew Irwin  
Telephone number: 02071447255

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Updated Category News Views 80

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 14

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Updated Category News Views 0

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 35

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Faith on Trial: La Luz del Mundo Faces Court Ruling

Updated Category News Views 21

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 194

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Updated Category News Views 0

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance

Updated Category News Views 39

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyxis Oncology Focuses on Breakthrough Therapy PYX-201

Updated Category News Views 205

Pyxis Oncology Redirects Focus to Leading Therapy PYX-201 Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage biotech firm, has announced a significant shift in its strategic direction by prioritizing its lead clinical program, PYX-201. This innovative antibody-drug conjugate (ADC) is engineered to target specific components within the tumor extracellular matrix, aiming...

Continue Reading
Ecovyst's Q3 Performance and Strategic Moves for Growth

Updated Category News Views 98

Ecovyst's Third Quarter Performance and Strategic Insights Ecovyst Inc. (NYSE: ECVT), a notable provider in the chemical industry, recently revealed its financial performance for the third quarter of 2025, showcasing significant progress in its operations and strategic decisions. The company specializes in the production of virgin sulfuric acid and regeneration services,...

Continue Reading
Consumer Interest Grows for Monthly AI Home Assistant Services

Updated Category News Views 447

Consumer Willingness to Invest in AI-Driven Home Solutions Recent research into consumer preferences reveals that a significant portion of the population is ready to embrace AI-assisted smart home technology. Parks Associates' compelling study finds that between 42% and 52% of consumers are inclined to subscribe to a monthly service for an AI smart home assistant that...

Continue Reading
Tuya Smart Introduces Hey Tuya: Revolutionizing Everyday AI Assistants

Updated Category News Views 186

Tuya Smart Unveils Hey Tuya: A Game-Changer in AI Technology In a notable advancement in AI technology, Tuya Smart (NYSE: TUYA) has introduced its innovative platform called Hey Tuya. This next-generation Super AI Life Assistant is set to redefine how individuals interact with artificial intelligence in their daily lives. The initiative represents a significant leap...

Continue Reading
Innovative Food Packaging Concept Redefines Convenience

Updated Category News Views 384

New Approach to Food and Beverage Packaging In an ever-evolving world where efficiency and convenience are paramount, an inventive solution has emerged. An inventor, motivated by the challenges of transporting, preparing, and storing food, has conceptualized an improved packaging design that promises to revolutionize these everyday tasks. Why This Invention Matters This...

Continue Reading